PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

NCT05732948 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: autologous T cells & cyclophosphamide

Sponsor

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Collaborators

[object Object]